Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cysteamine versus hydroquinone for facial melasma
ACTRN12619000406101Phase 3Terminated
- Sponsor
- Dr Michelle Rodrigues
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3 trial of cysteamine and hydroquinone, sponsored by Dr Michelle Rodrigues. Started May 2019; status: terminated.
02
Drugs
cysteaminehydroquinone
Beyond the preview
Go deeper on ACTRN12619000406101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000406101.